Cigarette smoke is a complex mixture of more than 4,000 constituents. Its effects on cell
biology are poorly understood, partly because whole smoke exposure in vitro is technically …

Nicotine pouches to be put under the upper lip are a new category of products that are
being rapidly developed and marketed as consumer goods with little research or regulatory …

The reported increase in the non-medical use of opioid prescription medication in West Africa
and Middle East coinciding with the ongoing problems in North America has moved the …

Aim: To assess prevalence of potentially malignant oral mucosal cavity lesions among
tobacco consuming migrant construction workers in sub-urban Chennai, India. Settings and …

Decades of research show that constituents other than nicotine are the harmful agents in
tobacco products. This knowledge is incorporated into the nicotine regulatory policies of …

Purpose The purpose of this paper is to review the barriers in the dissemination of effective
smoking cessation treatments and services globally. Offering tobacco users help to stop …

Despite substantial declines in cigarette smoking in England since the 1970s, around 20 per
cent of the adult population still smokes. In Sweden, 10 per cent of adult males and 12 per …

A wide range of microbes inhabit the oral cavity, and bacterial and fungal communities most
often exist as structured communities or biofilms. The use of tobacco alters the structure of …

Nicotine extracted from tobacco and purified from other constituents can be delivered in the
form of nicotine replacement products for helping people move away from tobacco …

Sirs, Gilmore et al. review ‘The place for harm reduction and product regulation in UK tobacco
control policy’, 1 including the challenges around smokeless tobacco products, such as …